| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Burroughs W |
Letter From A Master Addict To Dangerous Drugs |
British Journal of A... |
1956 |
| van der Horst L |
The way of working with "model" psychoses |
Advanc. psychosom. M... |
1960 |
| Stévenin L, Benoit JC |
A propos de l'utilisation des substances dysleptiques en psychothérapi... |
Encephale |
1960 |
| L Stevenin, JC Benoit |
A propos de l'utilisation des substances dysleptiques en psychotherapi... |
Encephale |
1960 |
| DC Cameron |
Drug Dependence: No Longer Can We "Let George Do It" |
Amer. J. Psychiat. (... |
1966 |
| |
Dependence on LSD and other hallucinogenic drugs |
Journal American Med... |
1967 |
| Fox RP |
A physician's guide to LSD |
GP |
1967 |
| Gilder SSB |
Amphetamine and LSD |
Canad. Med. Ass. J. |
1970 |
| Isbell H, Chrusciel TL |
Dependence liability of "non-narcotic" drugs |
Bull. Wld Hlth Org. |
1970 |
| Ladewig D |
Amphetamine and hallucinogen dependence in Europe |
Advances in neuropsy... |
1971 |
| Hawks DV |
The dimensions of drug dependence in the United Kingdom |
Int. J. Addict. |
1971 |
| Connell PH |
Hallucinogens |
Side effects of drug... |
1972 |
| Pittel SM |
Psychological Aspects of Heroin and Other Drug Dependence |
'It's So Good, Don't... |
1972 |
| Kaymakcalan S |
Tolerance to and dependence on cannabis. |
Bull.Narcotics |
1973 |
| Tarshis MS |
The LSD Controversy: an Overview |
Amer J Psychiat |
1973 |
| Brown JK, Malone MH |
Some U.S. street drug identification programs |
J Am Pharm Assoc |
1973 |
| Caldwell J, Sever PS |
The biochemical pharmacology of abused drugs 1. Amphetamines, cocaine,... |
Clin.Pharmacol.Ther. |
1974 |
| Kotas J, Vesely K, Pac J |
Oxidation of benzyl alcohol, allylbenzene, methyl benzyl ketone,and &2... |
Chem zvesti |
1974 |
| Freedman DX |
LSD, Psychotogenic Procedures, and Brain Neurohumors. |
Psychopharmacol Bull |
1975 |
| Loo H, Caroli F |
La Conduite Toxicomaniaque dens ses Rapports a la Conduite Suicidaire |
Ann.Med.-Psychol |
1975 |
| Kaymakcalan S |
Detection Of Dependence Producing Drugs In Body Fluids |
Ankara Univ. Tip Fak... |
1975 |
| Woodford WJ |
Rapid Screening Procedures For Some Strfet Drugs By Thin Layer Chromat... |
J. Chromatography |
1975 |
| Gershon MD, Robinson RG, ... |
Serotonin Accumulation in the Guinea-Pig Myenteric Plexus: Ion Depende... |
J.Pharmacol.Exp.Ther... |
1976 |
| Jantz L |
Probleme und Möglochkeiten ambulanter und stationäer Behandlune von Su... |
Therapiewoche |
1976 |
| Ovcharov R, Bantoutova I,... |
Pharmacological Analysis of Certain Mecharisms of Morphine Addiction |
Acta Physiol.Pharmac... |
1976 |
| Pradhan SN, Hollister LE |
Abuse Of LSD And Other Hallucinogenic Drugs |
Drug Abuse: Clinical... |
1977 |
| Weinstein H, Johnson CL, ... |
Molecular Determinants For The Action Of Tryptamines On An LSD Recepto... |
Fed. Proc. |
1977 |
| Blum K, Futterman SL, Pas... |
Peyote, a potential ethnopharmacologic agent for alcoholism and other ... |
Clin Toxicol |
1977 |
| Dube KC, Kumar A, Kumar N... |
Prevalence and pattern of drug use amongst college students |
Acta psychiat.scand. |
1978 |
| Kuhn DM, O'Callaghan JP, ... |
Activation of Brain Tryptophan Hydroxylase by ATP-Mg2+: Dependence on ... |
Proc.Natl Acad. Sci. |
1980 |
| Barnett G, Hawks R, Resni... |
Cocaine pharmacokinetics in humans |
J Ethnopharmacol |
1981 |
| Weil AT |
The therapeutic value of coca in contemporary medicine |
J Ethnopharmacol |
1981 |
| McNall SJ, Mansour TE |
Forskolin Activation Of Serotonin-stimulated Adenylate- Cyclase In The... |
Biochemical Pharmaco... |
1985 |
| Siegel RK |
Seduction of the innocent: a clinical note on the effects of cartoons ... |
J Psychoactive Drugs |
1985 |
| Schlemmer RF Jr, Nawara C... |
Influence of Environmental Context on Tolerance to LSD-Induced Behavio... |
Biol Psychiatry |
1986 |
| Gessa GL |
[Guidelines for the drug therapy of alcoholism] |
Recenti Prog Med |
1990 |
| De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
| Gordon Baumbacher, M.D., ... |
Abuse of Monoamine Oxidase Inhibitors |
Am J Drug Alcohol Ab... |
1992 |
| Stohler R, Rommelspacher ... |
[Beta-carbolines (harman/norharman) are increased in heroin dependent ... |
Ther Umsch |
1993 |
| LeSage M, Clark R, Poling... |
MDMA and memory: the acute and chronic effects of MDMA in pigeons perf... |
Psychopharmacology (... |
1993 |
| Gable RS |
Toward a Comparative Overview of Dependence Potential and Acute Toxici... |
Am J Drug Alcohol Ab... |
1993 |
| Azolosa JL, Stitzer ML, G... |
Opioid physical dependence development: effects of single versus repea... |
Psychopharmacology (... |
1994 |
| Anthony JC, Warner LA, Ke... |
Comparative Epidemiology of Dependence on Tobacco, Alcohol, Controlled... |
Experimental and Cli... |
1994 |
| Sarnyai Z, Kovacs GL |
Role of oxytocin in the neuroadaptation to drugs of abuse |
Psychoneuroendocrino... |
1994 |
| Dalgarno PJ, Shewan D |
Illicit use of ketamine in scotland |
J Psychoactive Drugs |
1996 |
| Halpern JH |
The Use of Hallucinogens in the Treatment of Addiction |
Addiction Research |
1996 |
| Beardsley PM, Balster RL,... |
Evaluation of the discriminative stimulus and reinforcing effects of g... |
Psychopharmacology (... |
1996 |
| Gerada C, Ashworth M |
ABC of mental health. Addiction and dependence--I: Illicit drugs [publ... |
BMJ |
1997 |
| Morgan AE, Horan B, Dewey... |
Repeated administration of 3,4-methylenedioxymethamphetamine augments ... |
Eur J Pharmacol |
1997 |
| Krupitsky EM, Grinenko AY |
Ketamine psychedelic therapy KPT: a review of the results of ten years... |
J Psychoactive Drugs |
1997 |
| Malberg JE, Seiden LS |
Small changes in ambient temperature cause large changes in 3,4-methyl... |
J Neurosci |
1998 |
| Schuster P, Lieb R, Lamer... |
Is the use of ecstasy and hallucinogens increasing? Results from a com... |
Eur Addict Res |
1998 |
| Sabol KE, Seiden LS |
Reserpine attenuates D-amphetamine and MDMA-induced transmitter releas... |
Brain Res |
1998 |
| Martellotta MC, Balducci ... |
Gamma-hydroxybutyric acid decreases intravenous cocaine self-administr... |
Pharmacol Biochem Be... |
1998 |
| Mash DC, Kovera CA, Buck ... |
Medication development of ibogaine as a pharmacotherapy for drug depen... |
Ann N Y Acad Sci |
1998 |
| Mash DC, Allen-Ferdinand ... |
[Ibogaine:] Clinical Observations of Safety after Single Oral Dose Adm... |
College on Problems ... |
1998 |
| Pablo J, Tyndale R, Obach... |
Pharmacokinetic Disposition of Ibogaine after Oral Administration to H... |
College on Problems ... |
1998 |
| Jansen KL |
Ecstasy (MDMA) dependence |
Drug Alcohol Depend |
1999 |
| Laviola G, Adriani W, Ter... |
Psychobiological risk factors for vulnerability to psychostimulants in... |
Neurosci Biobehav Re... |
1999 |
| Grotenhermen F |
[Some practice-relevant aspects of the pharmacokinetics of THC] |
Forsch Komplementarm... |
1999 |
| Tuchtenhagen F, Daumann J... |
High Intensity Dependence of Auditory Evoked Dipole Source Activity In... |
Neuropsychopharmacol... |
2000 |
| van Aerts LAGJM, Malleret... |
N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties ... |
Addiction Biology |
2000 |
| Horan B, Gardner EL, Ashb... |
Enhancement of conditioned place preference response to cocaine in rat... |
Synapse |
2000 |
| Walsh SL, Geter-Douglas B... |
Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pha... |
J Pharmacol Exp Ther |
2001 |
| Degenhardt L, Hall W |
The association between psychosis and problematical drug use among Aus... |
Psychol Med |
2001 |
| Perkins KA, Fonte C, Sand... |
Threshold doses for nicotine discrimination in smokers and non-smokers |
Psychopharmacology (... |
2001 |
| Heinälä P, Alho H, Kiianm... |
Targeted use of naltrexone without prior detoxification in the treatme... |
J Clin Psychopharmac... |
2001 |
| Croft, RJ, Klugman, A, Ba... |
Electrophysiological evidence of serotonergic impairment in lonf-term ... |
American Journal of ... |
2001 |
| Mamamoorthy Y, Tyndale R,... |
Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... |
Pharmacogenetics |
2001 |
| Tancer, ME, Johanson, C-E |
The subjective effects of MDMA and mCPP in moderate MDMA users |
Drug and Alcohol Dep... |
2001 |
| Cottler LB, Womack SB, Co... |
Ecstasy abuse and dependence among adolescents and young adults: appli... |
Hum Psychopharmacol ... |
2001 |
| Dughiero G, Schifano F, F... |
Personality dimensions and psychopathological profiles of Ecstasy user... |
Hum Psychopharmacol ... |
2001 |
| Alper KR, Beal D, Kaplan ... |
A contemporary history of ibogaine in the United States and Europe |
Alkaloids Chem Biol |
2001 |
| Todorovic SM, Jevtovic-To... |
Ca(v)3.2 channel is a molecular substrate for inhibition of T-type cal... |
Mol Pharmacol |
2001 |
| Ramamoorthy Y, Tyndale RF... |
Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... |
Pharmacogenetics |
2001 |
| Solowij N, Stephens RS, R... |
Cognitive functioning of long-term heavy cannabis users seeking treatm... |
JAMA |
2002 |
| Young R, Glennon RA |
The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5- g]isoquinol... |
Pharmacol Biochem Be... |
2002 |
| von Sydow K, Lieb R, Pfis... |
Use, abuse and dependence of ecstasy and related drugs in adolescents ... |
Drug and Alcohol Dep... |
2002 |
| Rothman R, Baumann M |
Therapeutic and adverse actions of serotonin transporter substrates |
Pharmacol Ther |
2002 |
| Eisen SA, Chantarujikapon... |
Does marijuana use have residual adverse effects on self-reported heal... |
Addiction |
2002 |
| Fergusson DM, Horwood LJ,... |
Cannabis dependence and psychotic symptoms in young people |
Psychol Med |
2003 |
| Lim DK |
Ketamine associated psychedelic effects and dependence |
Singapore Med J |
2003 |
| Passie T, Karst M, Borsut... |
Effects of different subanaesthetic doses of (S)-ketamine on psychopat... |
J Psychopharmacol |
2003 |
| Iversen L |
Cannabis and the brain |
Brain |
2003 |
| London ED, Simon SL, Berm... |
Mood disturbances and regional cerebral metabolic abnormalities in rec... |
Arch Gen Psychiatry |
2004 |
| Hanson KL, Luciana M |
Neurocognitive function in users of MDMA: the importance of clinically... |
Psychol Med |
2004 |
| Baggott MJ, Erowid E, Ero... |
Use of salvia divinorum, an unscheduled hallucinogenic plant: a web-ba... |
Clinical Pharmacolog... |
2004 |
| Nichols DE |
Hallucinogens |
Pharmacology & Thera... |
2004 |
| Pierre JM, Shnayder I, Wi... |
Intranasal quetiapine abuse |
Am J Psychiatry |
2004 |
| Chen SL, Huang EY, Chow L... |
Dextromethorphan differentially affects opioid antinociception in rats |
Br J Pharmacol |
2005 |
| Donovan JL, DeVane CL, Ma... |
Modafinil influences the pharmacokinetics of intravenous cocaine in he... |
Clin Pharmacokinet |
2005 |
| Ersche KD, Roiser JP, Cla... |
Punishment Induces Risky Decision-Making in Methadone-Maintained Opiat... |
Neuropsychopharmacol... |
2005 |
| Vega WA, Gil AG |
Revisiting drug progression: long-range effects of early tobacco use |
Addiction |
2005 |
| Halpern JH, Sherwood AR, ... |
Psychological and Cognitive Effects of Long-Term Peyote Use Among Nati... |
Biological Psychiatr... |
2005 |
| Robertson JR, Raab GM, Br... |
Addressing the efficacy of dihydrocodeine versus methadone as an alter... |
Addiction |
2006 |
| Gable RS |
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and har... |
Addiction |
2007 |
| Timberlake DS, Haberstick... |
Progression from marijuana use to daily smoking and nicotine dependenc... |
Drug Alcohol Depend |
2007 |
| Mintzer IL, Eisenberg M, ... |
Treating opioid addiction with buprenorphine-naloxone in community-bas... |
Ann Fam Med |
2007 |
| Addy P |
Facilitating transpersonal experiences with dextromethorphan: potentia... |
Journal of Transpers... |
2007 |
| Wee S, Wang Z, Woolverton... |
Effect of aripiprazole, a partial dopamine D2 receptor agonist, on inc... |
Neuropsychopharmacol... |
2007 |
